跳至主要内容
临床试验/NCT02142582
NCT02142582已完成不适用

Comparison of Different Oral Rehydration Solutions (ORS) in Short Bowel Syndrome (SBS) Patients on Home Parenteral Nutrition (HPN): A Prospective Double-blinded Randomized Controlled Trial.

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2014年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
28
试验地点
1
主要终点
Number of patients who will regularly take Oral Rehydration Solution (ORS) when the newly available ORS is compared to the World Health Organisation ORS.

研究概览

简要总结

Compliance is the biggest challenge in patients with Short Bowel Syndrome (SBS) on Home Parenteral Nutrition. These patients need to hydrate themselves to meet the excess fluid loss due to their anatomy. Oral Rehydration Solution (ORS) is prescribed to all these patients. The investigators believe that taste of the standard ORS is the biggest reason why these patients are not complaint. The new ORS in the market has been prepared with this in mind. The investigators want to study if this new ORS will improve the compliance in this patient cohort.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All patients with short bowel syndrome treated by the HPN program.

排除标准

  • •Participants who have do not provide written consent.
  • •Participants who lack the ability to provide informed consent
  • •Participants who are not anticipated to be on HPN for at least 6 months (determined by PrincipaI Investigator).
  • •Pregnant women
  • •Participants with pre-existing congestive heart failure, acute/ chronic kidney failure. (determined by the PrincipaI Investigator)

研究组 & 干预措施

WHO ORS

Active Comparator

Participants will be instructed to dilute contents of the provided ORS to a 1 liter bottle and sip all day.

干预措施: WHO ORS (Dietary Supplement)

Commercial ORS

Active Comparator

Participants will be instructed to dilute contents of the provided ORS to a 1 liter bottle and sip all day.

干预措施: Commercial ORS (Dietary Supplement)

结局指标

主要结局

Number of patients who will regularly take Oral Rehydration Solution (ORS) when the newly available ORS is compared to the World Health Organisation ORS.

时间窗: 6 months

次要结局

  • Changes in the electrolytes in subjects using the commercial ORS versus the WHO ORS(Baseline to 6 months)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ryan T. Hurt, M.D., Ph.D.

PI

Mayo Clinic

研究点 (1)

Loading locations...

相似试验